Haier Biomedical Won the 2022 Listed Company Low-Carbon Contribution Award

The 2022 International Green Zero-Carbon Festival & 2022 ESG Leaders’ Summit was held in Beijing recently. Themed by “the road to carbon neutrality”, the event set up the “Zero Carbon Prize” for the practitioners and leaders of green development. Adhering to the “environmental development” concept, Haier Biomedical has always been actively practicing the “dual carbon” responsibility, promoting energy conservation …

Microbiosci Releases LPS Extraction Service to Support Managing Endotoxins Issues

Microbiosci announced the release of its LPS extraction service to support managing endotoxins issues. New York, USA – September 30, 2022 – Microbiosci, the mature branch of Creative Biogene, is designed especially for accelerating the development of microbial industry. With unique technologies and satisfactory services in microbial genome editing, identification, sequencing, proteomics and metabolomics, Microbiosci …

Creative Proteomics Cytokine Boosts Biomarker Analysis with the Human Luminex Array Platform

Creative Proteomics Cytokine announced the launch of the Human Luminex Array Platform, which enables simultaneous analysis of multiple cytokines, chemokines, and other protein biomarkers in human serum, plasma, and cell culture samples. New York, USA – September 30, 2022 – Cytokine, a subdivision of Creative Proteomics, specializes in providing cytokine research and analytical services for …

CD Genomics RNA-Solutions Platform Now Provides Whole Transcriptome Sequencing Service

Scientists at CD Genomics are ready to help detect various types of RNAs via meticulous and integrative approaches. Powered by the Illumina, Pacbio SMRT, and Nanopore sequencing platforms, CD Genomics offers services performed by de novo and reference-based transcriptome analysis of the global transcriptome response. New York, USA – September 30, 2022 – RNA-Solutions is …

Creative Enzymes Announces the Start of Year-End Promotion on Its Kosher Certified Products

Creative Enzymes today announced extensive savings on the full range of Kosher Certified Products in its year-end promotion, which runs until December 29, 2022. New York, USA – September 30, 2022 – Creative Enzymes, a professional enzyme provider located in New York, USA, is always hammering away at research and trials in order to provide …

Accelerate Research with CD ComputaBio’s Full Range of Bioinformatics Services

CD ComputaBio recently announced the launch of bioinformatics services to meet the diverse research needs of its clients. New York, USA – September 30, 2022 – CD ComputaBio, a reliable computational biology service provider in New York, is committed to assisting research and trials, as well as accessing the latest software, technologies, and expertise at …

Creative Bioarray Offers a Broad Range of iPSC Reprogramming Kits to Accelerate Stem Cell Research

Creative Bioarray announced the release of its a broad range of iPSC reprogramming kits to accelerate stem cell research. New York, USA – September 30, 2022 – Creative Bioarray, one of the world’s leading biotechnology products and services providers, has been working hand-in-hand with scientists to provide the most cutting-edge and innovative research tools for …

A Robust Telomere Aging Clocks Platform Helps Conduct Lab-Grade Telomere Length Analysis

New York, USA – September 30, 2022 – A robust telomere aging clocks system combined with RF, qPCR, STELA, and TESLA techniques is newly reconfigured to conduct specialized lab-grade telomere length analysis and offer comprehensive pictures of biological aging. “With our integrated telomere aging clocks platform, researchers can utilize simple, fast, and scalable measurement to …

Creative Biogene Delivers Knockout Mouse Models to Support Gene Editing and Future Studies

Creative Biogene announced the release of its knockout mouse models to help understand biological mechanisms of genes and diseases in humans. New York, USA – September 30, 2022 – Crispr/cas9 platform, the division of Creative Biogene, is run by an international team of scientists with academic and industrial backgrounds, providing comprehensive gene editing services and …

Alfa Chemistry Launches Mxene Materials Helping to Unlock Future Nanotechnologies

New York, USA – September 30, 2022 – As various forms of nanomaterials have captured the interest of materials science researchers and developers over the last decade, the scientific team of Alfa Chemistry steps up efforts to further enlarge its product offerings. Fairly recently, the company announced the supply of Mxene materials, an innovative type …

Amerigo Scientific Launches PicoRaman Spectrometer for Time-resolved Measurements

Amerigo Scientific recently announced the launch of its new PicoRaman Spectrometer for biological and pharmaceutical applications. New York, USA – September 30, 2022 – Amerigo Scientific, a distributor focused on providing critical products and services to the biomedical and life science communities, recently announced the launch of its new PicoRaman Spectrometer for biological and pharmaceutical …

Profacgen Released a CDMO Platform for Drug Discovery and Development Research

Profacgen is pleased to release a leading CDMO platform that supports one-stop professional services from drug discovery to cGMP production for worldwide biopharmaceutical and biotechnology companies. New York, USA – September 30, 2022 – Profacgen, a biotechnology company dedicated to offering comprehensive one-stop services for pre-clinical drug development, is pleased to release a leading CDMO …

Artificial Intelligence in Oncology market is anticipated to grow at a CAGR of 54% till 2035 | Roots Analysis

Roots Analysis has announced the addition of “Artificial Intelligence in Oncology Market, 2022-2035” report to its list of offerings. The success of currently employed artificial intelligence (AI) solutions has encouraged researchers to explore the potential of such technologies in the healthcare sector, with its prime focus being oncology, to enable the treatment of several prevalent …

Open-angle Glaucoma Market to Register Growth at an Extraordinary CAGR by 2032 | DelveInsight

The Open-angle Glaucoma Market is expected to show positive growth in the forecast period (2022–2032) due to the development of well-designed, randomized, controlled non-crossover trials with potential benefits. Moreover, the shortfall of approved therapy might provide suitable space for emerging therapies. Key takeaways from the Open-angle Glaucoma Market Report As per DelveInsight’s analysis, a higher …

The Cold Agglutinin Disease was USD 59.9 million which is expected to rise during the study period (2019-2032).

The Cold Agglutinin Disease Market Insights report from DelveInsight provides a thorough understanding of the Cold Agglutinin Disease Market size by treatment, epidemiology, emerging therapies, Cold Agglutinin Disease market share of the various therapies, and the current and forecasted Cold Agglutinin Disease Market size from 2019 to 2032 divided into the 7MM (the USA, EU5 …

Aplastic Anemia Market to Register Growth at an Extraordinary CAGR by 2032

The Aplastic Anemia Market is expected to show positive growth in the forecast period (2022–2032) due to the development of well-designed, randomized, controlled non-crossover trials with potential benefits. Moreover, the shortfall of approved therapy might provide suitable space for emerging therapies. DelveInsight’s Aplastic Anemia Market Insights report includes a comprehensive understanding of current treatment practices, …

Hepatic Encephalopathy Market to Register Growth at an Extraordinary CAGR by 2032

The Hepatic Encephalopathy Market is expected to show positive growth in the forecast period (2022–2032) due to the development of well-designed, randomized, controlled non-crossover trials with potential benefits. Moreover, the shortfall of approved therapy might provide suitable space for emerging therapies. DelveInsight’s Hepatic Encephalopathy Market Insights report includes a comprehensive understanding of current treatment practices, …

Geographic Atrophy Market to Register Growth at an Extraordinary CAGR by 2032, DelveInsight | Major Companies – Apellis, Iveric Bio, Roche, CellCure Neurosciences, Hemera Biosciences, and Others

The Geographic Atrophy Market is expected to show positive growth in the forecast period (2022–2032) due to the development of well-designed, randomized, controlled non-crossover trials with potential benefits. Moreover, the shortfall of approved therapy might provide suitable space for emerging therapies. DelveInsight’s Geographic Atrophy Market Insights report includes a comprehensive understanding of current treatment practices, …

Graves’ Disease Market to Register Growth at an Extraordinary CAGR by 2032, DelveInsight | Major Companies – Novartis, and Several Others

The Graves ’ disease Market is expected to show positive growth in the forecast period (2022–2032) due to the development of well-designed, randomized, controlled non-crossover trials with potential benefits. Moreover, the shortfall of approved therapy might provide suitable space for emerging therapies. DelveInsight’s Graves’ Disease Market Insights report includes a comprehensive understanding of current treatment …

Intratumoral Cancer Therapies Market to Register Growth at an Extraordinary CAGR by 2032, DelveInsight| Key Players-Checkmate Pharmaceuticals, OncoSec Medical Incorporated, and Many Others

The Intratumoral Cancer Therapies Market is expected to show positive growth in the forecast period (2022–2032) due to the development of well-designed, randomized, controlled non-crossover trials with potential benefits. Moreover, the shortfall of approved therapy might provide suitable space for emerging therapies.   Key takeaways from the Intratumoral Cancer Therapies Market Report As per DelveInsight’s …